Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act

Tanja R Zijp; Martha L Toren-Wielema; Prashant V Nannan Panday; Jos G W Kosterink; Stefan P Berger; Daan J Touw

doi:10.1097/FTD.0000000000000766

Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act

Tanja R Zijp, Martha L Toren-Wielema, Prashant V Nannan Panday, Jos G W Kosterink, Stefan P Berger, Daan J Touw^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

48 Downloads (Pure)

Original language	English
Pages (from-to)	652-653
Number of pages	2
Journal	Therapeutic Drug Monitoring
Volume	42
Issue number	4
Early online date	2020
DOIs	https://doi.org/10.1097/FTD.0000000000000766
Publication status	Published - Aug-2020

Access to Document

10.1097/FTD.0000000000000766Licence: CC BY-NC-ND

Important_interactions_of_immunosuppressants_withFinal author's version, 321 KBLicence: CC BY-NC-ND
Important_Interactions_of_Immunosuppressants_With.21Final publisher's version, 95.7 KBLicence: CC BY-NC-ND

Cite this

@article{9ee1ef6899b8494bb3b0d04b2c6a2ed4,

title = "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act",

author = "Zijp, {Tanja R} and Toren-Wielema, {Martha L} and {Nannan Panday}, {Prashant V} and Kosterink, {Jos G W} and Berger, {Stefan P} and Touw, {Daan J}",

year = "2020",

month = aug,

doi = "10.1097/FTD.0000000000000766",

language = "English",

volume = "42",

pages = "652--653",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "4",

}

Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19) : how to act. / Zijp, Tanja R; Toren-Wielema, Martha L ; Nannan Panday, Prashant V ; Kosterink, Jos G W ; Berger, Stefan P ; Touw, Daan J.

In: Therapeutic Drug Monitoring, Vol. 42, No. 4, 08.2020, p. 652-653.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19)

T2 - how to act

AU - Zijp, Tanja R

AU - Toren-Wielema, Martha L

AU - Nannan Panday, Prashant V

AU - Kosterink, Jos G W

AU - Berger, Stefan P

AU - Touw, Daan J

PY - 2020/8

Y1 - 2020/8

U2 - 10.1097/FTD.0000000000000766

DO - 10.1097/FTD.0000000000000766

M3 - Comment/Letter to the editor

C2 - 32433189

VL - 42

SP - 652

EP - 653

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 4

ER -